Valuation: Navamedic ASA

Market Cap 388M 39.49M 34.51M 31.69M 29.55M 56.02M 3.76B 56.97M 382M 148M 1.84B 148M 145M 6.35B P/E 2026 *
270x
P/E 2027 * 24.2x
Enterprise Value 494M 50.27M 43.92M 40.33M 37.61M 71.31M 4.79B 72.51M 486M 188M 2.35B 189M 185M 8.09B EV / Sales 2026 *
0.83x
EV / Sales 2027 * 0.67x
Free-Float
71.72%
Yield 2026 *
-
Yield 2027 * -
1 day+4.94%
1 week+4.29%
Current month+3.98%
1 month-0.29%
3 months-13.71%
6 months-23.77%
Current year-28.57%
1 week 16.1
Extreme 16.1
17.25
1 month 15.7
Extreme 15.7
18
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8
Extreme 8
43.9
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2019
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 01/06/2022
Director/Board Member - 01/06/2023
Director/Board Member 60 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
19/12/24Buy

Chief Operating Officer

10,267 0.0581%
09/09/24Fiscal year

Chief Operating Officer

75,000 0.4302%
09/09/24Fiscal year

Executive/Senior Manager

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+4.94%+4.29%-24.11%-56.41% 39.49M
+3.45%+7.65%+55.77%+158.84% 1,082B
-1.16%+7.42%+69.09%+58.92% 633B
-0.77%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.56%+1.17%+41.96%+39.64% 301B
-0.08%+1.49%+32.40%+44.75% 292B
-1.54%+2.58%-25.52%-39.75% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+0.40%+6.00%+17.72%+70.33% 163B
Average +1.84%+2.50%+26.15%+46.35% 369.98B
Weighted average by Cap. +1.37%+1.96%+42.23%+81.71%

Financials

2026 *2027 *
Net sales 595M 60.48M 52.85M 48.53M 45.26M 85.8M 5.76B 87.25M 584M 226M 2.82B 227M 222M 9.73B 661M 67.19M 58.71M 53.91M 50.28M 95.31M 6.4B 96.92M 649M 252M 3.14B 252M 247M 10.81B
Net income 1M 102K 88.82K 81.56K 76.06K 144K 9.68M 147K 982K 381K 4.75M 382K 373K 16.36M 16M 1.63M 1.42M 1.31M 1.22M 2.31M 155M 2.35M 15.71M 6.09M 75.94M 6.11M 5.97M 262M
Net Debt 106M 10.77M 9.42M 8.65M 8.06M 15.28M 1.03B 15.54M 104M 40.34M 503M 40.46M 39.58M 1.73B 57M 5.79M 5.06M 4.65M 4.34M 8.22M 552M 8.36M 55.98M 21.69M 271M 21.76M 21.28M 932M
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
03/07/26 NOK 17.00 +4.94% 30,323
02/07/26 NOK 16.20 -0.92% 147
01/07/26 NOK 16.35 0.00% 5,482
30/06/26 NOK 16.35 0.00% 25,263
29/06/26 NOK 16.35 +0.31% 16,769
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
16.20NOK
Average target price
26.00NOK
Spread / Average Target
+60.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock